Navigation Links
Life Sciences Discovery Fund makes grant awards to commercialize promising technologies

SEATTLE, Washington, March 11, 2013 The Life Sciences Discovery Fund (LSDF) today announced nearly $750,000 in Proof of Concept grants to three Washington organizations to support transition of promising health-related technologies from concept to commercial product. Also announced was up to $1.4 million in matching funds to the University of Washington to foster technology commercialization, conditioned upon that institution receiving a larger federal grant. LSDF will also sponsor an experienced entrepreneur to determine the most appropriate commercialization pathway for "smart home" technology developed at Washington State University through two prior grants.

Two of the Proof of Concept grants were awarded to early-stage companies to fund prototype development or data collection needed to secure private equity investment. OtoMetrix Medical Technologies, Inc. (principal investigator Mark Kraus) will create and test a prototype device for rapid and accurate diagnosis of middle ear infections. RJS Biologics, LLC (principal investigator Stephen McCraith) will develop and test targeted therapies for cancer.

A Proof of Concept grant also was awarded to Dr. Lawrence Loeb at the University of Washington to further develop a highly accurate DNA sequencing method that could enhance cancer early detection, treatment selection, and assessment of disease recurrence.

The conditional grant to the University of Washington would be the first Opportunity award for the 2012-2013 funding cycle. Opportunity grants support initiatives that significantly leverage LSDF dollars against those from other sources. Dr. Charles Murry will lead a new program to translate commercially viable technologies in the area of cardiovascular, lung, and blood diseases from the laboratory to the market. LSDF funding would be provided contingent upon receipt of a multi-million dollar grant from the National Institutes of Health and would be further matched by contributions from participating organizations.

The "entrepreneur in residence" at Washington State University will develop strategies for commercializing technology that monitors the elderly in their own residences and helps keep them out of nursing homes. The new funding, to be provided as a supplement to an ongoing grant to Diane Cook, will be matched by monies from Washington State University.

"LSDF has directly funded the commercial development of diagnostic and therapeutic products in Washington since 2007, and we are pleased to add three new Proof of Concept awards to our portfolio," stated LSDF executive director John DesRosier. "Through our newest Opportunity grant, we also expect to support a commercialization infrastructure with the capacity to shepherd multiple 'homegrown' technologies from idea to impact."

The LSDF Board of Trustees made the final award selections following review of proposals for scientific and technical merit, commercial potential, and possible health and economic benefits.

"The board has previously invested in Dr. Cook's work to develop 'smart home' technology, which has the power to keep the elderly independent and safe in their homes and may reduce costs for institutional care," stated board chair Lura Powell. "This technology needs to get into the commercial marketplace to have maximum impact, and we are happy to provide supplemental funding to help determine the best way to do so."

Contact: Cathyryne Manner
Life Sciences Discovery Fund

Related medicine news :

1. NAS receives $3.5 million gift to establish Prize in Psychological and Cognitive Sciences
2. New Wiley Open Access title launches: Journal of Medical Radiation Sciences
3. Dr. Lewis Cantley awarded $3 million breakthrough prize in life sciences
4. Advanced Technologies Bring Record Growth to Charm Sciences in Its 35th Year
5. TraceLink Life Sciences Cloud Named Edison Awards Finalist
6. TraceLink Life Sciences Cloud Named Amazon AWS Grand Prize Winner for Protecting Patients, Enabling Health, Ensuring Track and Trace Compliance
7. Twelfth annual Wiley Prize in Biomedical Sciences awarded
8. Feinstein Institute Scientist Wins Crafoord Award from Royal Swedish Academy of Sciences for Arthritis Research
9. Sancilio and Company Announces Life Sciences Consulting Services
10. ILVO-T&V Belgium Validates Charm Sciences ROSA Beta-Lactam and Tetracycline 2-Minute Test for Raw, Commingled, Bovine Milk to be Imported by Customs Union Countries
11. Vascular Health Sciences Introduces Executive and Advisory Team
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology: